Andrew S. Bomback

Andrew S. Bomback

Nephrology

161 Fort Washington Avenue
Floor 2, Suite 202
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 183 publications

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

Journal: The New England journal of medicine

Published: June 05, 2026

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Journal: Kidney international

Published: April 28, 2026

Primary Glomerular Diseases in the Elderly: Clinical Features, Treatment Patterns, and Outcomes in the CureGN Cohort.

Primary Glomerular Diseases in the Elderly: Clinical Features, Treatment Patterns, and Outcomes in the CureGN Cohort.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 26, 2026

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

Journal: medRxiv : the preprint server for health sciences

Published: March 13, 2026

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

Journal: JAMA network open

Published: March 11, 2026

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Journal: Advances in therapy

Published: February 17, 2026

Complement biomarkers during iptacopan treatment - Authors' reply.

Complement biomarkers during iptacopan treatment - Authors' reply.

Journal: Lancet (London, England)

Published: February 12, 2026

Acute tubular injury versus acute interstitial nephritis in the kidney precision medicine project.

Acute tubular injury versus acute interstitial nephritis in the kidney precision medicine project.

Journal: JCI insight

Published: December 30, 2025

Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy.

Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 16, 2025

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Journal: The New England journal of medicine

Published: December 03, 2025

Opportunities and challenges in recurrent diffuse podocytopathy post-transplantation: the critical value of the definition.

Opportunities and challenges in recurrent diffuse podocytopathy post-transplantation: the critical value of the definition.

Journal: Frontiers in immunology

Published: October 30, 2025

Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes.

Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes.

Journal: Nature communications

Published: October 09, 2025

Showing 1-12 of 183

Last Updated: 09/26/2026